Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007121631> ?p ?o ?g. }
- W3007121631 abstract "To explore the dosimetric improvement, delivery efficiency, and plan robustness for bilateral head and neck cancer (HNC) treatment utilizing a novel proton therapy technique - the spot-scanning proton arc (SPArc) therapy.We evaluated fourteen bilateral HNC patients retrospectively. Both SPArc and 3-field Intensity Modulated Proton Therapy (IMPT) plans were generated for each patient using the same robust optimization parameters. The prescription doses were 70Gy (relative biological effectiveness (RBE) for CTV_high and 60Gy[RBE] for CTV_low. Clinically significant dosimetric parameters were extracted and compared. Root-mean-square deviation dose (RMSDs) Volume Histogram(RVH) was used to evaluate the plan robustness. Total treatment delivery time was estimated based on the machine parameters.The SPArc plan was able to provide equivalent or better robust target coverage while showed significant dosimetric improvements over IMPT in most of the organs at risk (OARs). More specifically, it reduced the mean dose of the ipsilateral parotid, contralateral parotid, and oral cavity by 25.8%(p = 0.001), 20.8%(p = 0.001) and 20.3%(p = 0.001) respectively compared to IMPT. This technique reduced D1 (the maximum dose covering 1% volume of a structure) of cord and brain stem by 20.8% (p = 0.009) and 10.7% (p = 0.048), respectively. SPArc also reduced the average integral dose by 17.2%(p = 0.001) and external V3Gy (the volume received 3Gy[RBE]) by 8.3%(p = 0.008) as well. RVH analysis showed that the SPArc plans reduced the dose uncertainties in most OARs compared to IMPT, such as cord: 1.1 ± 0.4Gy[RBE] vs 0.7 ± 0.3Gy[RBE](p = 0.001), brain stem: 0.9 ± 0.7Gy[RBE] vs 0.7 ± 0.7Gy[RBE](p = 0.019), contralateral parotid: 2.5 ± 0.5Gy[RBE] vs 2.2 ± 0.6Gy[RBE](p = 0.022) and ipsilateral parotid: 3.1 ± 0.7Gy[RBE] vs 2.8 ± 0.6Gy[RBE](p = 0.004) respectively. The average total estimated treatment delivery time were 283.4 ± 56.2 s, 469.2 ± 62.0 s and 1294.9 ± 106.7 s based on energy-layer-switching-time (ELST) of 0.1 s, 1 s, and 5 s respectively for SPArc plans, compared to the respective values of 328.0 ± 47.6 s(p = 0.002), 434.1 ± 52.0 s(p = 0.002), and 901.7 ± 74.8 s(p = 0.001) for 3-field IMPT plans. The potential clinical benefit of utilizing SPArc will lead to a decrease in the mean probability of salivary flow dysfunction by 31.3%(p = 0.001) compared with IMPT.SPArc could significantly spare OARs while providing a similar or better robust target coverage compared with IMPT in the treatment of bilateral HNC. In the modern proton system with ELST less than 0.5 s, SPArc could potentially be implemented in the routine clinic with a practical, achievable treatment delivery efficiency." @default.
- W3007121631 created "2020-03-06" @default.
- W3007121631 creator A5014335750 @default.
- W3007121631 creator A5031178158 @default.
- W3007121631 creator A5041391309 @default.
- W3007121631 creator A5047855118 @default.
- W3007121631 creator A5052648220 @default.
- W3007121631 creator A5055888843 @default.
- W3007121631 creator A5064218700 @default.
- W3007121631 creator A5068845250 @default.
- W3007121631 creator A5072574772 @default.
- W3007121631 date "2020-01-30" @default.
- W3007121631 modified "2023-10-01" @default.
- W3007121631 title "Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study" @default.
- W3007121631 cites W1967967795 @default.
- W3007121631 cites W1983869432 @default.
- W3007121631 cites W1997498511 @default.
- W3007121631 cites W2004006404 @default.
- W3007121631 cites W2011307344 @default.
- W3007121631 cites W2015091362 @default.
- W3007121631 cites W2029728138 @default.
- W3007121631 cites W2047204133 @default.
- W3007121631 cites W2049517861 @default.
- W3007121631 cites W2075639390 @default.
- W3007121631 cites W2081389407 @default.
- W3007121631 cites W2091388764 @default.
- W3007121631 cites W2094591030 @default.
- W3007121631 cites W2098507748 @default.
- W3007121631 cites W2101018924 @default.
- W3007121631 cites W2102192086 @default.
- W3007121631 cites W2102907744 @default.
- W3007121631 cites W2111273332 @default.
- W3007121631 cites W2112482103 @default.
- W3007121631 cites W2118142039 @default.
- W3007121631 cites W2118772763 @default.
- W3007121631 cites W2124893411 @default.
- W3007121631 cites W2127494183 @default.
- W3007121631 cites W2141997640 @default.
- W3007121631 cites W2142227180 @default.
- W3007121631 cites W2145944546 @default.
- W3007121631 cites W2160948062 @default.
- W3007121631 cites W2280232957 @default.
- W3007121631 cites W2297571891 @default.
- W3007121631 cites W2329205749 @default.
- W3007121631 cites W2470147592 @default.
- W3007121631 cites W2516454733 @default.
- W3007121631 cites W2612527208 @default.
- W3007121631 cites W2623075369 @default.
- W3007121631 cites W2744169094 @default.
- W3007121631 cites W2771009687 @default.
- W3007121631 cites W2792386706 @default.
- W3007121631 cites W2884120442 @default.
- W3007121631 cites W2909225564 @default.
- W3007121631 cites W2910552628 @default.
- W3007121631 cites W2946000200 @default.
- W3007121631 doi "https://doi.org/10.1186/s13014-020-1476-9" @default.
- W3007121631 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6990547" @default.
- W3007121631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32000817" @default.
- W3007121631 hasPublicationYear "2020" @default.
- W3007121631 type Work @default.
- W3007121631 sameAs 3007121631 @default.
- W3007121631 citedByCount "20" @default.
- W3007121631 countsByYear W30071216312020 @default.
- W3007121631 countsByYear W30071216312021 @default.
- W3007121631 countsByYear W30071216312022 @default.
- W3007121631 countsByYear W30071216312023 @default.
- W3007121631 crossrefType "journal-article" @default.
- W3007121631 hasAuthorship W3007121631A5014335750 @default.
- W3007121631 hasAuthorship W3007121631A5031178158 @default.
- W3007121631 hasAuthorship W3007121631A5041391309 @default.
- W3007121631 hasAuthorship W3007121631A5047855118 @default.
- W3007121631 hasAuthorship W3007121631A5052648220 @default.
- W3007121631 hasAuthorship W3007121631A5055888843 @default.
- W3007121631 hasAuthorship W3007121631A5064218700 @default.
- W3007121631 hasAuthorship W3007121631A5068845250 @default.
- W3007121631 hasAuthorship W3007121631A5072574772 @default.
- W3007121631 hasBestOaLocation W30071216311 @default.
- W3007121631 hasConcept C126838900 @default.
- W3007121631 hasConcept C201645570 @default.
- W3007121631 hasConcept C2775881188 @default.
- W3007121631 hasConcept C2776530083 @default.
- W3007121631 hasConcept C2779244869 @default.
- W3007121631 hasConcept C2989005 @default.
- W3007121631 hasConcept C509974204 @default.
- W3007121631 hasConcept C71924100 @default.
- W3007121631 hasConcept C75088862 @default.
- W3007121631 hasConceptScore W3007121631C126838900 @default.
- W3007121631 hasConceptScore W3007121631C201645570 @default.
- W3007121631 hasConceptScore W3007121631C2775881188 @default.
- W3007121631 hasConceptScore W3007121631C2776530083 @default.
- W3007121631 hasConceptScore W3007121631C2779244869 @default.
- W3007121631 hasConceptScore W3007121631C2989005 @default.
- W3007121631 hasConceptScore W3007121631C509974204 @default.
- W3007121631 hasConceptScore W3007121631C71924100 @default.
- W3007121631 hasConceptScore W3007121631C75088862 @default.
- W3007121631 hasIssue "1" @default.
- W3007121631 hasLocation W30071216311 @default.
- W3007121631 hasLocation W30071216312 @default.
- W3007121631 hasLocation W30071216313 @default.
- W3007121631 hasLocation W30071216314 @default.